최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecular carcinogenesis, v.3 no.6, 1990년, pp.350 - 362
Bacus, Sarah S. , Kiguchi, Kaoru , Chin, Dot , King, C. Richter , Huberman, Eliezer
AbstractThe relationship between terminal cell differentiation and changes in the subcellular levels of the HER‐2/neu antigen was investigated in cultured human breast cancer cells: AU‐565 cells (which overexpress the HER‐2/neu gene) and MCF‐7 cells (which do not overexpr...
Semba, K, Kamata, N, Toyoshima, K, Yamamoto, T. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.. Proceedings of the National Academy of Sciences of the United States of America, vol.82, no.19, 6497-6501.
Coussens, L, Yang-Feng, TL, Liao, YC, Chen, E, Gray, A, McGrath, J, Seeburg, PH, Libermann, TA, Schlessinger, J, Francke, U, et, al.. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, vol.230, no.4730, 1132-1139.
Bargmann, Cornelia I., Hung, Mien-Chie, Weinberg, Robert A.. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, vol.319, no.6050, 226-230.
Slamon, DJ, Clark, GM, Wong, SG, Levin, WJ, Ullrich, A, McGuire, WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, vol.235, no.4785, 177-182.
van de Vijver, Marc J., Peterse, Johannes L., Mooi, Wolter J., Wisman, Peter, Lomans, Job, Dalesio, Otilia, Nusse, Roel. Neu-Protein Overexpression in Breast Cancer. The New England journal of medicine, vol.319, no.19, 1239-1245.
King, CR, Kraus, MH, Aaronson, SA. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science, vol.229, no.4717, 974-976.
Cancer Res Berger MS 1238 48 1988 Correlation of c‐erbB‐2 gene amplification and protein expression in human breast cancer with nodal status and nuclear grading
Oncogene Varley JM 423 1 1987 Alterations to either c‐erbB‐2 (neu) or c‐myc protoncogenes in breast carcinomas correlate with poor short‐term prognosis
Cancer Res Zhou D 6123 47 1987 Association of multiple copies of the c‐erbB‐2 oncogene with spread of breast cancer
Paik, S, Hazan, R, Fisher, E R, Sass, R E, Fisher, B, Redmond, C, Schlessinger, J, Lippman, M E, King, C R. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.8, no.1, 103-112.
Yokota, J., Toyoshima, K., Sugimura, T., Yamamoto, T., Terada, M., Battifora, H., Cline, M.. AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO. The Lancet, vol.327, no.8484, 765-767.
Slamon, DJ, Godolphin, W, Jones, LA, Holt, JA, Wong, SG, Keith, DE, Levin, WJ, Stuart, SG, Udove, J, Ullrich, A, et, al.. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, vol.244, no.4905, 707-712.
Carpenter, G, Cohen, S. Epidermal Growth Factor. Annual review of biochemistry, vol.48, 193-216.
Levi-Montalcini, Rita. The nerve growth factor thirty-five years later. In vitro cellular & developmental biology : journal of the Tissue Culture Association, vol.23, no.4, 227-238.
Cancer Res Sachs L 1981 47 1987 Cell differentiation and bypassing of growth defects in the suppression of malignancy
Progress in Cancer Research and Therapy Huberman E 247 1988
Yamamoto, Tadashi, Ikawa, Shuntaro, Akiyama, Tetsu, Semba, Kentaro, Nomura, Nobuo, Miyajima, Nobuyuki, Saito, Toshiyuki, Toyoshima, Kumao. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature, vol.319, no.6050, 230-234.
Di Fiore, PP, Pierce, JH, Kraus, MH, Segatto, O, King, CR, Aaronson, SA. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science, vol.237, no.4811, 178-182.
Hudziak, R M, Schlessinger, J, Ullrich, A. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.. Proceedings of the National Academy of Sciences of the United States of America, vol.84, no.20, 7159-7163.
Blood Knight RD 634 69 1987 10.1182/blood.V69.2.634.634 Inosine monophosphate dehydrogenase and myeloid cell maturation
Sidi, Y., Panet, C., Wasserman, L., Cyjon, A., Novogrodsky, A., Nordenberg, J.. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.. The British journal of cancer, vol.58, no.1, 61-63.
Kiguchi, Kaoru, Collart, Frank R., Henning-Chubb, Cynthia, Huberman, Eliezer. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin. Experimental cell research, vol.187, no.1, 47-53.
Cell Growth and Differentiation Kiguchi K 259 1 1990 Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: Altered patterns of IMP dehydrogenase expression and activity
Cancer Res Huberman E 2618 39 1979 Stimulation of differentiation functions in human melanoma cells by tumor‐promoting agents and dimethyl sulfoxide
Huberman, E, Callaham, M F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents.. Proceedings of the National Academy of Sciences of the United States of America, vol.76, no.3, 1293-1297.
Rovera, G, Santoli, D, Damsky, C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.. Proceedings of the National Academy of Sciences of the United States of America, vol.76, no.6, 2779-2783.
Abe, Miyako, Kufe, Donald. Effects of maturational agents on expression and secretion of two partially characterized high molecular weight milk‐related glycoproteins in MCF‐7 breast carcinoma cells. Journal of cellular physiology, vol.126, no.1, 126-132.
Cancer Res Lotan R 1014 39 1979 Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid‐induced growth inhibition
Retinoids and Cell Differentiation Lotan R 61 1986
Oncogene McKenzie SJ 543 4 1989 Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, P185
Kraus, M.H., Popescu, N.C., Amsbaugh, S.C., King, C.R.. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.. The EMBO journal, vol.6, no.3, 605-610.
Theory and Practice of Histotechnology Sheehan DC 209 1980
Cheung, M K, Cunningham-Rundles, C, Koistinen, J. Cross-reactive idiotypes in immunoglobulin A-deficient sera.. The Journal of clinical investigation, vol.75, no.5, 1722-1728.
Am J Pathol Bacus S 783 135 1989 Biological grading of breast cancer using antibodies to proliferating cells and other markers
Arch Pathol Lab Med Bacus SS 164 114 1990 HER‐2/neu oncogene expression and DNA ploidy analysis in breast cancer
Molecular Cloning: A Laboratory Manual Maniatis T 1982
J Biol Chem Collart FR 15769 263 1988 10.1016/S0021-9258(19)37654-9 Cloning and sequence analysis of the human and Chinese hamster inosine‐5′‐monophosphate dehydrogenase cDNAs
Towbin, H, Staehelin, T, Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.. Proceedings of the National Academy of Sciences of the United States of America, vol.76, no.9, 4350-4354.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.